The Role of Adipose-Derived MSCs in Autism Spectrum Disorder: Neuroimmune Modulation and Clinical Evidence
Date: May 10, 2025
Duration: 60 Minutes
Time: 3 PM EST
Autism Spectrum Disorder (ASD) is increasingly understood as a condition influenced by neuroinflammation, immune dysregulation, gut-brain axis imbalance, and impaired neuronal communication. Adipose-derived mesenchymal stem cells (AD-MSCs) offer a targeted therapeutic approach due to their neuroprotective, anti-inflammatory, and immune-modulating properties. AD-MSCs have demonstrated the ability to reduce microglial activation, regulate cytokine imbalance, support neuronal repair, and improve gastrointestinal dysfunction commonly associated with ASD. This webinar explores the growing clinical evidence supporting AD-MSC therapy in ASD and how cellular modulation may contribute to improvements in behavior, communication, emotional regulation, and sensory integration.
Why you should attend?
This session provides a comprehensive overview of the biological pathways that make AD-MSCs a promising modality for ASD management. Clinicians will learn how neuroimmune interactions impact ASD symptoms and how AD-MSC therapy may help restore homeostasis in the CNS and immune system. We will review clinical outcomes, trial data, and case-based improvements in communication, social engagement, and behavioral stability. The webinar will also cover considerations for patient selection, delivery methods, and safety monitoring.
Areas Covered in the Session:
- What AD-MSCs are and their relevance in neuroimmune disorders
- Mechanisms of neuroinflammation reduction in ASD
- Immune modulation and cytokine balancing effects
- Gut-brain axis stabilization and microbiome implications
- Clinical outcomes: communication, behavior, sensory integration
- Review of published studies and global clinical experience
- Protocol design, safety guidance, and follow-up monitoring
Who will benefit:
- Neurology and developmental specialists
- Pediatric regenerative medicine providers
- Functional and integrative medicine clinicians
- Autism treatment centers and therapy programs
- Physicians, NPs, PAs, and researchers in neuroimmune disorders
Webinar Fee
Prices are in US Dollars.
The registration fee includes: The live webinar & all related course materials.
Terms & Conditions to register for the Webinar
Your Registration for the workshop is subject to following terms and conditions. If you need any clarification before registering for this webinar please email us at info@fdamap.com
Payment
We accept credit card, debit card, and PayPal.
Cancellations & Substitutions:
Written cancellations through fax or email (from the person who has registered for this conference) received at least 5 business days prior to the start date of the event will receive a refund — less a $30 administration fee. No cancellations will be accepted — nor refunds issued — within 5 business days before the start date of the event. You may however, choose to substitute the webinar for which you are registered with some other webinar in the future.
On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($30) will be transferred to any future FDA Map event and a credit note will be issued. No-shows will be charged the full amount.
Webinar material will be uploaded on the website 24 hours before the scheduled date of the webinar. In case it is not available on the website due to some technical issues, we will email the material a few hours before the start of the webinar.
In the event FDA Map cancels the webinar, FDA Map will issue a full refund to all the registrants for that webinar. Some topics and speakers may be subject to change without notice.
For any information on the training agenda and logistics, please call +1 877 566 4981 or email: info@fdamap.com
